Your browser doesn't support javascript.
loading
Assessment of the Acute Effects of 2C-B vs. Psilocybin on Subjective Experience, Mood, and Cognition.
Mallaroni, Pablo; Mason, Natasha L; Reckweg, Johannes T; Paci, Riccardo; Ritscher, Sabrina; Toennes, Stefan W; Theunissen, Eef L; Kuypers, Kim P C; Ramaekers, Johannes G.
Afiliación
  • Mallaroni P; Department of Neuropsychology and Psychopharmacology, Faculty of Psychology and Neuroscience, Maastricht University, Maastricht, The Netherlands.
  • Mason NL; Department of Neuropsychology and Psychopharmacology, Faculty of Psychology and Neuroscience, Maastricht University, Maastricht, The Netherlands.
  • Reckweg JT; Department of Neuropsychology and Psychopharmacology, Faculty of Psychology and Neuroscience, Maastricht University, Maastricht, The Netherlands.
  • Paci R; Department of Neuropsychology and Psychopharmacology, Faculty of Psychology and Neuroscience, Maastricht University, Maastricht, The Netherlands.
  • Ritscher S; Institute of Legal Medicine, University Hospital, Goethe University, Frankfurt/Main, Germany.
  • Toennes SW; Institute of Legal Medicine, University Hospital, Goethe University, Frankfurt/Main, Germany.
  • Theunissen EL; Department of Neuropsychology and Psychopharmacology, Faculty of Psychology and Neuroscience, Maastricht University, Maastricht, The Netherlands.
  • Kuypers KPC; Department of Neuropsychology and Psychopharmacology, Faculty of Psychology and Neuroscience, Maastricht University, Maastricht, The Netherlands.
  • Ramaekers JG; Department of Neuropsychology and Psychopharmacology, Faculty of Psychology and Neuroscience, Maastricht University, Maastricht, The Netherlands.
Clin Pharmacol Ther ; 114(2): 423-433, 2023 08.
Article en En | MEDLINE | ID: mdl-37253161

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Psilocibina / Alucinógenos Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: Clin Pharmacol Ther Año: 2023 Tipo del documento: Article País de afiliación: Países Bajos

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Psilocibina / Alucinógenos Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: Clin Pharmacol Ther Año: 2023 Tipo del documento: Article País de afiliación: Países Bajos